MDPediatrix Medical Group, Inc.
$26.65+64% 1Y
$26.65
$15.8052 weeks$27.07
The financials
Pediatrix Medical Group, Inc. by the numbers
Pediatrix Medical Group, Inc. (MD) reported revenue of $488M in Q2 2026 (quarter ended Jun 30, 2026), up 4.0% from the same quarter a year earlier. That came with net income of $40M (8.2% of revenue). For the full year FY2025, revenue was $1.91B (−4.9% year on year) and net income $165M. Its largest product in Q2 2026 was Health Care Patient Service at $419M, 86% of the disclosed total, well ahead of Hospitals Contracts at 14%. The next results filing is expected around Nov 2, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $488M | $469M | +4.0% |
| Operating income | $57M | $60M | −4.9% |
| Net income | $40M | $39M | +1.5% |
| Diluted EPS | $0.49 | $0.46 | +6.5% |
| Product | Revenue | Share |
|---|---|---|
| Health Care Patient Service | $419M | 86% |
| Hospitals Contracts | $68M | 14% |
| Product And Service Other | $779K | 0.2% |
Business segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q2 2026Total $487.8M (+2.4%)
Health Care Patient Service grew +5.4% year on yearProduct And Service Other -76% year on year
Segment Latestquarter on quarteryear on year
- Health Care Patient Service$418.7M$418.7Mquarter on quarter +3.3%year on year +5.4%+3.3%+5.4%
- Hospitals Contracts$68.3M$68.3Mquarter on quarter -2.3%year on year +0.12%-2.3%+0.12%
- Product And Service Other$779.0K$779.0Kquarter on quarter -16%year on year -76%-16%-76%
On our screens:Cheap stocks by free cash flow yield